Background Analysis: US FDA Advisory Committee to Hear Updates on the 21st Century Cures Act, National Antibiotics Strategy, and More (SBFDA)
The U.S. FDA has added a meeting of the Science Board to the FDA (SBFDA) for Wednesday, July 29, 2015. The Science Board will be provided with a report from the Commissioner’s Fellowship Program Evaluation subcommittee and will be provided with a progress report from the Science Looking Forward subcommittee. The Board will hear an overview of two scientific activities from the Center for Veterinary Medicine and will be asked to provide input on strategies to implement targeted directives contained in the National Strategy for Combating Antibiotic - Resistant Bacteria, designed to guide action by public health, health care, and veterinary partners in a common effort to address urgent and serious drug - resistant threats that affect people in the United States and around the world. A recipient of one of the Fiscal Year 2014 Scientific Achievement Awards (selected by the Board) will provide an overview of the activities for which the award was given. A status update on the 21st Century Cures Act will be presented, and the Deputy Commissioner for Medical Products and Tobacco will discuss his vision for the Office of Medical Products and Tobacco.